Sunday, September 14th, 2025

Chularat Hospital: Poised for Strong 4Q24 with Higher Revenue per Adjusted RW

Date of Report: October 1, 2024
Broker: CGS-CIMB Securities Malaysia Sdn. Bhd.

Company Overview

Chularat Hospital is a Thailand-based healthcare provider offering a wide range of medical services. The hospital group operates multiple facilities and serves a broad patient base, focusing on delivering quality healthcare services in the region.

Financial Performance

Chularat Hospital is expected to perform well in 4Q24, with anticipated revenue of THB7,200 per adjusted RW (Relative Weight), reflecting strong operational efficiency and an increase in patient volume. The hospital’s financial outlook is promising, driven by improvements in both patient inflow and service offerings.

Revenue Drivers

The revenue growth for Chularat Hospital in the fourth quarter is largely attributed to a rise in the adjusted RW metric. This increase indicates the hospital’s ability to generate higher revenue per patient, which is a positive indicator of the company’s financial health and profitability.

Investment Recommendation

The report maintains an “Add” recommendation for Chularat Hospital, with an increased target price (TP) of THB3.10. The positive outlook is supported by the hospital’s consistent ability to enhance revenue per adjusted RW and its growing patient base, both of which signal long-term growth potential.

Conclusion

Chularat Hospital is poised for a strong 4Q24 performance, with a notable increase in revenue per adjusted RW. This growth, coupled with the hospital’s strong operational framework, supports the “Add” recommendation and revised higher target price of THB3.10. The company’s steady expansion and financial health make it a compelling investment in the healthcare sector.

CelcomDigi (CDB MK) 1Q25 Results: Strong Profit Growth, Integration Progress, and 2025 Outlook – Target Price RM4.30

UOB Kay Hian 23 May 2025 CelcomDigi 1Q25 Results: Steady Growth, Strategic Integration, and Attractive Dividend Yield Investment Highlights: CelcomDigi Maintains BUY Rating with 9.7% Upside Potential CelcomDigi Berhad, one of Malaysia’s leading mobile...

Singapore REITs Outlook 2025: Navigating Transition with Quality and Value Picks

Comprehensive Analysis of Singapore REITs – January 2025 Comprehensive Analysis of Singapore REITs Broker Name: Maybank Research Date of Report: January 8, 2025 Introduction Singapore’s Real Estate Investment Trusts (REITs) sector is entering a...

Keppel (KEP SP) Sells M1 Assets for S$1.43b, Unlocks S$1b for Growth – Target Price Raised to S$10.46 (BUY Rating)

UOB Kay Hian Private Limited August 12, 2025 Keppel Ltd’s S\$1 Billion M1 Divestment: Unlocking Value and Fueling Future Growth Overview: Strategic Move Sets Stage for New Growth Keppel Ltd, a leading asset manager...